Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/CIMA-AEMPS/ISOTIORGA 40 MG CAPSULAS BLANDAS

Approved

STANDARD

ISOTIORGA 40 MG CAPSULAS BLANDAS

Laboratoires Bailleul S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: May 19, 2022
Approval ID: c5c41c2133d11672
Company: Laboratoires Bailleul S.A.
Type: Standard

Approval Details

Approval Id: c5c41c2133d11672
Drug Cima Aemps Name: ISOTIORGA 40 MG CAPSULAS BLANDAS
Register Number: 86649
Holder Company Name: Laboratoires Bailleul S.A.
Marketing Company Name: Laboratoires Bailleul S.A.
Authorization Date: 2022-05-19
Dosage Form: CÁPSULA BLANDA
Dose: 40 mg
Route Of Administration: VÍA ORAL
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Laboratoires Bailleul S.A.

Active Ingredients

ISOTRETINOINA

40 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 19, 2022

Approval ID

c5c41c2133d11672

Type

Standard

Back to CIMA-AEMPS Approvals

ISOTIORGA 40 MG CAPSULAS BLANDAS - CIMA-AEMPS Drug Approval Details